Eun-Sil Shelley Hwang, MD, on DCIS: Results of the CALGB 40903 Trial

2017 San Antonio Breast Cancer Symposium

Eun-Sil Shelley Hwang, MD, of Duke University Medical Center, discusses study findings on primary endocrine therapy for estrogen receptor–positive ductal carcinoma in situ (Abstract GS5-05).

Aug

Today In Oncology

Drug Combination Design for Multiple Myeloma Using an AI Platform

FDA Grants Clearance of PowerLook Density Assessment for Digital Breast Tomosynthesis

Definitive Pelvic Radiation Therapy Plus Chemotherapy and Survival in Newly Diagnosed Metastatic Cervical Cancer

Impact of Peer-Review Intervention on Radiotherapy Schedules for Palliative Treatment of Bone Metastases

FDA Grants Breakthrough Device Designation for Cancer Detection Liquid Biopsy

;